Concepedia

Author

Véronique Mary

Sanofi (France)

Also Known As

Veronique Mary, Véronique Mary, Véronique Mary

14

Publications

565

Citations

9

H-Index

37

Concepts

All Affiliations

Sanofi (France)Commissariat à l'Énergie Atomique et aux Énergies AlternativesCentre National de la Recherche Scientifique
VM

About

Véronique Mary is an author at Sanofi (France) specializing in medicine, neuroscience, and neuropharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

346

2

Social Sciences

2

2

192

3

Engineering

1

1

39

4

Biochemistry

1

1

114

5

Chemical Engineering

1

1

39

Véronique Mary

×

8

Publications

503

Citations

8

H-Index

YearCitations

Comparative study of voltage-sensitive sodium channel blockers in focal ischaemia and electric convulsions in rodents

Jean Rataud, Florence Debarnot, Véronique Mary,

Neuroscience Letters

1994

115

Oxygen activation at the plasma membrane: relation between superoxide and hydroxyl radical production by isolated membranes

Eiri Heyno, Véronique Mary, Peter Schöpfer,

Planta

2011

114

Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury

Florence Wahl, Emmanuelle Renou, Véronique Mary,

Brain Research

1997

77

Enoxaparin in Experimental Stroke

Véronique Mary, Florence Wahl, André Uzan,

Stroke

2001

55

Heterologous Expression of Human α6β4β3α5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the α5 Subunit

Vladimir P. Grinevich, Sharon R. Letchworth, Kari A. Lindenberger,

Journal of Pharmacology and Experimental Therapeutics

2005

44

Riluzole Reduces Incidence of Abnormal Movements but Not Striatal Cell Death in a Primate Model of Progressive Striatal Degeneration

Stéphane Palfi, D. Riché, Emmanuel Brouillet,

Experimental Neurology

1997

40

Applying DBP models to full‐scale plants

Paul Westerhoff, Jean Debroux, Gary Amy,

American Water Works Association

2000

39

SAR110894, a potent histamine H3‐receptor antagonist, displays disease‐modifying activity in a transgenic mouse model of tauopathy

Philippe Delay‐Goyet, Véronique Blanchard, Nathalie Schussler,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2016

19

Page 1